Plasma procoagulant phospholipid clotting time and venous thromboembolism risk

Background - Negatively charged procoagulant phospholipids, phosphatidylserine (PS) in particular, are vital to coagulation and expressed on the surface membrane of extracellular vesicles. No previous study has investigated the association between plasma procoagulant phospholipid clotting time (PPL...

Full description

Bibliographic Details
Published in:Research and Practice in Thrombosis and Haemostasis
Main Authors: Ramberg, Cathrine, Wilsgård, line, Latysheva, Nadezhda, Brækkan, Sigrid Kufaas, Hindberg, Kristian, Sovershaev, Timofey, Snir, Omri, Hansen, John Bjarne
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2021
Subjects:
Online Access:https://hdl.handle.net/10037/23804
https://doi.org/10.1002/rth2.12640
Description
Summary:Background - Negatively charged procoagulant phospholipids, phosphatidylserine (PS) in particular, are vital to coagulation and expressed on the surface membrane of extracellular vesicles. No previous study has investigated the association between plasma procoagulant phospholipid clotting time (PPL CT ) and future risk of venous thromboembolism (VTE). Objectives - To investigate the association between plasma PPL CT and the risk of incident VTE in a nested case-control study. Methods - We conducted a nested case-control study in 296 VTE patients and 674 age- and sex-matched controls derived from a general population cohort (The Tromsø Study 1994–2007). PPL CT was measured in platelet-free plasma using a modified factor Xa-dependent clotting assay. Logistic regression was used to estimate odds ratio (OR) with 95% confidence intervals (CI) for VTE with PPL CT modelled as a continuous variable across quartiles and in dichotomized analyses. Results - There was a weak inverse association between plasma PPL CT and risk of VTE per 1 standard deviation increase of PPL CT (OR 0.93, 95% CI 0.80–1.07) and when comparing those with PPL CT in the highest quartile (OR 0.89, 95% CI 0.60–1.30) with those in the lowest quartile. Subjects with PPL CT >95th percentile had substantially lowered OR for VTE (OR 0.35, 95% CI 0.13–0.81). The inverse association was stronger when the analyses were restricted to samples taken shortly before the event. The risk estimates by categories of plasma PPL CT were similar for deep vein thrombosis and pulmonary embolism. Conclusion - Our findings suggest that high plasma PPL CT is associated with reduced risk of VTE.